Neurocrine Bio. (NBIX) PT Raised to $142 at Deutsche Bank
Tweet
Share
E-mailGet Alerts NBIX Hot Sheet
Price: $154.49 +1.16%
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Rating Summary:
30 Buy, 6 Hold, 0 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 23 | New: 22
Join SI Premium – FREE
Deutsche Bank analyst David Hoang raised the price target on Neurocrine Bio. (NASDAQ: NBIX) to $142.00 (from $140.00) while maintaining a Hold rating.
You May Also Be Interested In
- Freedom Broker Upgrades PrimeEnergy Resource (PNRG) to Hold
- JD Logistics Inc (2618:HK) (JDLGF) PT Raised to HK$18.50 at Macquarie
- E Ink Holdings Inc (8069:TT) PT Lowered to NT$200 at Macquarie
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
